Are Investors Undervaluing AstraZeneca PLC (LON:AZN) By 49%?
Does the May share price for AstraZeneca PLC ( LON:AZN ) reflect what it’s really worth? Today, we will estimate the…
May 30, 2021
US airline pilot admits to lewd act in cockpit mid-flight – Stuff.co.nz
The former Southwest pilot pleaded guilty to exposing his genitals to a female first officer and watching pornography on a laptop during a flight.
In visions of post-pandemic life, Roaring ’20s beckon again
NEW YORK — History repeats itself. But do decades duplicate?
Microsoft Senior Program Manager says “Good Company”
From Microsoft Senior Program Manager(Past Employee – 2,020)‐ Rating 5 out of 5 — Sat, 29 May 2021ProsMassive Services and complex systems to work onBest benefits…
Stock Analysis
VIXC – Market and Financial News Online Magazine.
VIXC provides financial news, data and commentary including stock quotes, press releases, financial reports, and original content. Leading online magazine source…
‘They started massacring people’: Army deployed as 13 people killed in Colombia protests
Colombian authorities are unable to contain the fury of increasingly politicised youth battered by the pandemic and angered about the country’s deep inequalities….
Bitcoin mining difficulty decreases by 16% from its recent all-time-high – The Block Crypto
The network’s hash rate has already dropped significantly from its recent all-time-high prior to China’s bitcoin mining crackdown comment.
Uncorrelated Assets – Part II – Pay Attention To What Hasn’t Performed Well
The point with uncorrelated assets is that these are typically stocks that are out-of-favor, get little interest from the media and are reasonably-valued relative…
444 days in the making: Canadian NHL fans return for Leafs-Habs playoff series
Crowds returned to Canadian NHL rinks on Saturday, as 2,500 fans were allowed inside the Bell Centre for Game 6 of the Montreal Canadiens vs. Toronto Maple Leafs…
Biogen in the spotlight as FDA action date for Alzheimer’s therapy approaches
The scientists, public advocacy groups, and analysts offer contrasting views as FDA is set to decide on aducanumab, the experimental therapy co-developed by Biogen…